International Council for Harmonisation E6(R2) addendum: Challenges of implementation
Author:
Open Access
- 1 October 2017
- journal article
- opinion
- Published by Wolters Kluwer Health in Perspectives in Clinical Research
- Vol. 8 (4) , 162-166
Abstract
The International Council for Harmonisation (ICH) E6 – good clinical practice (GCP) (R2) addendum – was released in 2016 to encourage implementation of improved approaches for the management of clinical trials. The changes in different sections include new approaches – quality management system, risk-based monitoring with emphasis on human subject protection, and data integrity. The article discusses challenges in adoption and implementation of the changes in ICH GCP guideline for clinical trial stakeholders.Keywords
This publication has 2 references indexed in Scilit:
- Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma’s Approach, Part 2Therapeutic Innovation & Regulatory Science, 2016
- Commercializing Clinical Trials — Risks and Benefits of the CRO BoomNew England Journal of Medicine, 2007